136 related articles for article (PubMed ID: 12681364)
1. Analysis of HLA-G expression in malignant hematopoetic cells from leukemia patients.
Poláková K; Krcová M; Kuba D; Russ G
Leuk Res; 2003 Jul; 27(7):643-8. PubMed ID: 12681364
[TBL] [Abstract][Full Text] [Related]
2. Activation of HLA-G expression by 5-aza-2 - deoxycytidine in malignant hematopoetic cells isolated from leukemia patients.
Polakova K; Bandzuchova E; Sabty FA; Mistrik M; Demitrovicova L; Russ G
Neoplasma; 2009; 56(6):514-20. PubMed ID: 19728760
[TBL] [Abstract][Full Text] [Related]
3. Binding analysis of HLA-G specific antibodies to hematopoietic cells isolated from leukemia patients.
Poláková K; Bandzuchová E; Hofmeister V; Weiss EH; Hutter H; Russ G
Neoplasma; 2003; 50(5):331-8. PubMed ID: 14628085
[TBL] [Abstract][Full Text] [Related]
4. Expression of HLA-G in patients with B-cell chronic lymphocytic leukemia (B-CLL).
Giannopoulos K; Dmoszyńska A; Bojarska-Junak A; Schmitt M; Roliński J
Folia Histochem Cytobiol; 2008; 46(4):457-60. PubMed ID: 19141398
[TBL] [Abstract][Full Text] [Related]
5. Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by gammaIFN treatment.
Frumento G; Franchello S; Palmisano GL; Nicotra MR; Giacomini P; Loke YW; Geraghty DE; Maio M; Manzo C; Natali PG; Ferrara GB
Tissue Antigens; 2000 Jul; 56(1):30-7. PubMed ID: 10958353
[TBL] [Abstract][Full Text] [Related]
6. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules.
Menier C; Saez B; Horejsi V; Martinozzi S; Krawice-Radanne I; Bruel S; Le Danff C; Reboul M; Hilgert I; Rabreau M; Larrad ML; Pla M; Carosella ED; Rouas-Freiss N
Hum Immunol; 2003 Mar; 64(3):315-26. PubMed ID: 12590976
[TBL] [Abstract][Full Text] [Related]
7. HLA-G class I gene expression in normal and malignant hematopoietic cells.
Amiot L; Onno M; Drénou B; Monvoisin C; Fauchet R
Hum Immunol; 1998 Aug; 59(8):524-8. PubMed ID: 9712358
[TBL] [Abstract][Full Text] [Related]
8. Mild acid treatment induces cross-reactivity of 4H84 monoclonal antibody specific to nonclassical HLA-G antigen with classical HLA class I molecules.
Poláková K; Bennink JR; Yewdell JW; Bystrická M; Bandzuchová E; Russ G
Hum Immunol; 2003 Feb; 64(2):256-64. PubMed ID: 12559628
[TBL] [Abstract][Full Text] [Related]
9. Expression of HLA G in human tumors is not a frequent event.
Real LM; Cabrera T; Collado A; Jimenez P; Garcia A; Ruiz-Cabello F; Garrido F
Int J Cancer; 1999 May; 81(4):512-8. PubMed ID: 10225437
[TBL] [Abstract][Full Text] [Related]
10. Uveal melanoma: no expression of HLA-G.
Hurks HM; Valter MM; Wilson L; Hilgert I; van den Elsen PJ; Jager MJ
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3081-4. PubMed ID: 11726606
[TBL] [Abstract][Full Text] [Related]
11. Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer.
Jung YW; Kim YT; Kim SW; Kim S; Kim JH; Cho NH; Kim JW
Reprod Sci; 2009 Nov; 16(11):1103-11. PubMed ID: 19692629
[TBL] [Abstract][Full Text] [Related]
12. Analysis of HLA-G gene expression in B-lymphocytes from chronic lymphocytic leukemia patients.
Rezvany MR; Kazemi A; Hajifathali A; Kaviani S; Mellstedt H
Iran Biomed J; 2007 Apr; 11(2):125-129. PubMed ID: 18051955
[TBL] [Abstract][Full Text] [Related]
13. Soluble HLA-G molecules are increased in lymphoproliferative disorders.
Sebti Y; Le Friec G; Pangault C; Gros F; Drénou B; Guilloux V; Bernard M; Lamy T; Fauchet R; Amiot L
Hum Immunol; 2003 Nov; 64(11):1093-101. PubMed ID: 14602240
[TBL] [Abstract][Full Text] [Related]
14. Looking for HLA-G expression in human tumours.
Real LM; Cabrera T; Canton J; Oliva R; Ruiz-Cabello F; Garrido F
J Reprod Immunol; 1999 Jul; 43(2):263-73. PubMed ID: 10479062
[TBL] [Abstract][Full Text] [Related]
15. Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production.
Urosevic M; Kurrer MO; Kamarashev J; Mueller B; Weder W; Burg G; Stahel RA; Dummer R; Trojan A
Am J Pathol; 2001 Sep; 159(3):817-24. PubMed ID: 11549573
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
[TBL] [Abstract][Full Text] [Related]
17. HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker?
Erikci AA; Karagoz B; Ozyurt M; Ozturk A; Kilic S; Bilgi O
Hematology; 2009 Apr; 14(2):101-5. PubMed ID: 19298722
[TBL] [Abstract][Full Text] [Related]
18. Ocular surface epithelial cells up-regulate HLA-G when expanded in vitro on amniotic membrane substrates.
Higa K; Shimmura S; Shimazaki J; Tsubota K
Cornea; 2006 Jul; 25(6):715-21. PubMed ID: 17077667
[TBL] [Abstract][Full Text] [Related]
19. Demethylating agent 5-aza-2'-deoxycytidine activates HLA-G expression in human leukemia cell lines.
Poláková K; Bandzuchová E; Kuba D; Russ G
Leuk Res; 2009 Apr; 33(4):518-24. PubMed ID: 18823661
[TBL] [Abstract][Full Text] [Related]
20. Comparative reactivity of different HLA-G monoclonal antibodies to soluble HLA-G molecules.
Fournel S; Huc X; Aguerre-Girr M; Solier C; Legros M; Praud-Brethenou C; Moussa M; Chaouat G; Berrebi A; Bensussan A; Lenfant F; Le Bouteiller P
Tissue Antigens; 2000 Jun; 55(6):510-8. PubMed ID: 10902607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
